Peer-influenced content. Sources you trust. No registration required. This is HCN.
Verywell Health
A Lilly spokesperson told Verywell that about 10% of people who start taking Zepbound for the first time enroll in the self-pay program. This includes people who previously used compounded tirzepatide.
Clinical Pharmacology April 8th 2025
Infectious Disease Advisor
The preservation of Medicare drug price negotiations alongside the removal of other cost-reduction measures creates a complex landscape for healthcare delivery and patient access.
All Specialties February 6th 2025
Medical News Today (MNT)
Medicare supplement plans can significantly reduce out-of-pocket costs for beneficiaries, covering expenses such as copayments, coinsurance, and deductibles not included in Original Medicare.
All Specialties October 10th 2024
Oncology News Central (ONC)
Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.
Clinical Pharmacology August 26th 2024
Annals of Internal Medicine
The annual cost of cancer screening represents a notable portion of overall U.S. health care system costs related to cancer, with private insurance covering the majority of expenses.
Hematology/Oncology August 12th 2024
PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.
Hematology/Oncology July 29th 2024